Show me the money : perspectives on applying for government research and development co-funding by Kearns, Nick & Beale, William
Number 2/2015
ISSN 2324-3635
Show me the Money: 
Perspectives on Applying for 
Government Research and 
Development Co-funding
Nick Kearns 
William Beale
paper series
occasional
discussion
&
 
 
 
 
 
 
 
 
OCCASIONAL AND  
DISCUSSION PAPER SERIES 2/2015 
 
Show me the Money: Perspectives on Applying for Government Research and 
Development Co-funding 
 
By Nick Kearns and William Beale 
  
 
 
 
Show me the money: Perspectives on applying for government research and development co-funding by Nick Kearns and  
William Beale, is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. 
 
This publication may be cited as: 
Kearns, N. and Beale, W. (2015). Show me the money: Perspectives on applying for government research and development. Unitec 
ePress Occasional and Discussion Paper Series (2). Retrieved from http://www.unitec.ac.nz/epress/ 
 
About this series: 
Unitec ePress periodically publishes occasional and discussion papers that discuss current and ongoing research authored by 
members of staff and their research associates.  All papers are blind reviewed. For more papers in this series please visit: 
www.unitec.ac.nz/epress/index.php/category/publications/epress-series/discussion-and-occasional -papers/ 
 
Cover design by Penny Thomson 
 
Contact: 
epress@unitec.ac.nz 
www.unitec.ac.nz/epress/ 
Unitec Institute of Technology 
Private Bag 92025, Victoria Street West 
Auckland 1142 
New Zealand 
 
 
 
ISSN 2324-3635  
  
 
 1 
Show me the Money: Perspectives on Applying for 
Government Research and Development Co-funding 
 
Authors 
 
Nick Kearns 
Department of Management and Marketing 
Unitec Institute of Technology 
 
William Beale 
The Innovation Workshop 
 
Abstract 
In 2012-14 Unitec Institute of Technology (in 
partnership with The Innovation Workshop) carried out 
research into the application process for New Zealand 
Government Research & Development [R&D] co-
funding administered by the Ministry of Science & 
Innovation (now Callaghan Innovation Ltd). This 
research revealed widespread applicant frustration with 
the application criteria and process.  A significant 
problem perceived by High Value Manufacturing and 
Service Small Medium Enterprises (HVMS SME) 
businesses is the focus of R&D funding on product 
innovation followed by a lack of funding to support 
later stage commercialisation of products. This later 
stage of product and market development is excluded 
from Callaghan Innovation co-funding, leading to 
‘prototypes-on-a-shelf’.  Applicants also found the 
process time consuming, due to the complexity of the 
application questions and the delays in response from 
the funding network of regional funding partners and 
the Government Ministry.  HVMS SME often used 
consultants to help manage the application, which is 
frowned upon by both the regional funding partners and 
Callaghan Innovation, despite the high levels of co-
funding success from these applicants. This work has 
been carried out during the establishment period of 
Callaghan Innovation Ltd and some of the above issues 
may be historic and/or transitional as the institutional 
arrangements change.  This research records the HVMS 
SME experience in applying for R&D co-funding. 
Consideration of the user experience, captured in this 
research, may reveal opportunities to improve the 
process with better outcomes for the applicants and the 
economy. 
 
Introduction 
New Zealand has long been a primary produce exporter 
with heavy reliance on meat and dairy products as the 
mainstay of our export earnings. Successive governments 
of all political persuasions have recognised the need to 
diversify our economy away from such commodities and 
into higher value goods. 
One of the tools used to support existing 
businesses, and also to bring about change in the export 
mix, is government co-funding of research and 
development. The R&D co-funding arena has been 
undergoing change over the last few years as the 
government seeks to increase efficiencies and drive their 
platform policy for economic growth as outlined in the 
Business Growth Agenda (New Zealand Government, 
2014). 
Prior to July 2012 the Ministry of Science & 
Innovation [MSI] was responsible for administering R&D 
co-funding to the business sector.  In July 2012, MSI 
became part of the newly created Ministry of Business, 
Innovation & Employment [MBIE]. Following that, 
responsibility for business R&D funding was transferred 
to Callaghan Innovation when it was established as a 
stand-alone Crown Entity in February, 2013. 
Callaghan Innovation is the Advanced Technology 
Institute [ATI] called for by various reports commissioned 
by the government with a view to accelerating the growth 
of the economy (New Zealand Government, Cabinet 
Economic Growth and Infrastructure Committee, 2012). 
One critical aspect of Callaghan Innovation is the role 
to act as “a single front door to the innovation system” 
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(Joyce 2013), giving businesses a one-stop-shop for: 
 
• Advice for businesses on innovation 
• Co-funding of business research and development 
• Provision of research and technical services 
 
Research had shown that the support and funding 
provision for business innovation was fragmented, 
difficult to access and not well understood by the 
potential clients (Martin, Jenkins & Associates Limited, 
2012). Callaghan Innovation was designed to pull these 
threads together into one more easily accessible and 
widely understood operation. 
As an ATI, Callaghan Innovation maintained the 
employment of 320 scientists from Industrial Research 
Limited [IRL], a Crown Research Institute [CRI] that was 
disestablished as Callaghan Innovation was established. It 
is this resource which provides the research and technical 
services.  
In addition to this, Callaghan Innovation has taken 
over the administration of the MBIE co-funding portfolio, 
and in October 2013 announced a new range of co-
funding products (Joyce, 2013). 
Callaghan Innovation has taken some time to find 
the necessary staff and set operating procedures, given 
the challenge of integrating new and existing elements 
(such as 320 IRL staff) into a new entity. As the end of 
2014 approached they had largely completed staffing and 
were consolidating into the role of being “a single front 
door to the innovation system”(Joyce 2013).  
The concept of a New Zealand National Innovation 
System [NIS] has been in the literature since Engelbrecht 
& Darroch (1999) argued that New Zealand had a weak 
NIS (in comparison to nations from the Organization for 
Economic Cooperation and Development [OECD]). This is 
despite a raft of changes being made to the research 
science and technology sector since the 1980s. More 
recent assessments of our NIS. Lerner, Moore & Shepherd 
(2005)  identify high levels of research publication but 
below-OECD-average business R&D investment, low 
levels of commercialisation of research results, and low 
levels of patenting (New Zealand Government Treasury, 
2008).  
A key function of the NIS is to source and support 
innovative businesses, and one of the mechanisms for this 
in New Zealand is the R&D co-funding provided by the 
government. As the structure of the NIS in New Zealand 
takes shape, this research focuses on that funding process 
from the perspective of small innovative businesses, who 
are the intended users of the system. 
The need for a dynamic small and medium 
enterprise [SME] sector with the capability to innovate 
and scale new products is central to the diversification of 
the New Zealand economy and the institutional changes 
to make this happen are well thought out and researched 
at the macro-economic level. There is also a need for the 
microeconomic (or individual firm) perspective to be 
considered as the processes will operate in a business led 
manner (Joyce, 2013, p3). If the processes do not serve the 
individual businesses well, then the system as a whole 
will ‘fail to fire’. 
This research arises from the need to understand 
HVMS SME perspective on the R&D co-funding 
application process more closely, so that any identified 
problems can be resolved during the time of change as 
Callaghan Innovation takes shape, and before the 
situations “refreezes” (Lewin, 1948 cited in Nelson & 
Quick, 2009, p. 292). 
Anecdotal feedback from many SME businesses in 
west and north Auckland had suggested that the R&D co-
funding application process was arduous, time consuming, 
uncertain, and many who had applied once would not do 
so again. This is a worrying observation if the feedback 
provided proves accurate. In a co-funding regime that is 
characterised as a business led approach to funding in 
which the initiative rests with the applicant (Joyce, 2013) 
it appears the system may be frustrating the clients it 
seeks to attract. 
To check the veracity of the anecdotal evidence 
regarding the difficulty of R&D co-funding applications, a 
series of qualitative interviews with eleven HVMS SME 
and three larger HVMS funding recipients was completed. 
This research was conducted with a view to developing a 
research tool for use with a much larger sample of HVMS 
businesses to gain a quantitative perspective.  
The interviews provided strong support for the view that 
the application process was not working smoothly. They 
also raised questions on whether New Zealand has a 
National Innovation System [NIS], and if so, how well the 
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NIS is working, and how it might be improved - from the 
perspective of the co-funding applicant.  
Two key findings emerged from the research; 1) the need 
for further work on the place of R&D co-funding on the 
‘path-to-market’ and other funding options for market 
development from within the NIS and, 2) the strongly held 
and opposing views on the use of consultants to help with 
completing co-funding applications. 
 
Literature Review 
A predominant theme in the literature on innovation in 
New Zealand is the need for an effective NIS (Raine, 
Teicher & O’Reilly, 2011; Boven, 2009; Lewis, 2008), as 
well as various attempts to evaluate the success of the 
NIS (Englebrecht & Darroch, 1999), or lack of success of 
the NIS (Oxley, Hong & McCann, 2013) at lifting New 
Zealand’s economic ranking in the OECD. The references 
listed here generally take a macro-economic approach, 
and discussions are at the level of institutional 
arrangements (Raine et al, 2011), industry or sector 
analysis (Hartwich & Negro, 2010), and policy 
recommendations for either government or industry 
bodies (Raine et al, 2011; Collier & Gray, 2010). 
Reviews of the functioning of the NIS (or similar 
arrangements) that have been undertaken focus on 
operational policy settings and factors such as economic 
conditions affecting R&D co-funding uptake  (Carran & 
Stroombergen, 2009). The sampling of businesses by 
Carran & Stroombergen (2009) was based on taking the 
largest co-funding grants awarded during the study 
period, which also meant only the largest businesses were 
interviewed.  
As most businesses are not large, and given the 
widespread understanding that successful innovation is 
more often found in SME than larger businesses, any 
research that excludes SME through sampling practices 
such as taking only the largest funding awards, cannot be 
seen as representative. 
These are valuable contributions to considering 
the New Zealand Innovation System as high-level design, 
analysis and implementation guides, but they leave a gap 
in the literature as to how some, if not most, of the 
intended users (HVMS SME) of the NIS see it working.  
International research on this topic also focuses 
on institutional arrangements at the macro level. The EU 
foreshadows the New Zealand experience with trends 
such as funding agencies independent from government 
and decentralised funding decision-making emerging 
from the mid 1990s. Similarly seeking more flexibility 
through different funding products has been dominant in 
EU policy since 2000 (Radosevic & Lepori, 2009).   
The EU literature states the importance of trying 
to balance issues of local and global relevance, 
(recognising that SME goals may be different to the 
macro-economic goals) as well as the need for diversity in 
the R&D funding applicants. Resultantly governmental 
objectives of excellence can be well served by 
competition among the applicants (Radosevic & Lepori, 
2009). The systemic perspective revealed in Radosevic & 
Lepori is very similar to much of the New Zealand based 
work on R&D funding processes. 
Other research highlights the impact of limited 
financial resources on R&D and how SME are more 
affected by this than larger firms (Czarnitzki, 2006). 42% 
of West German SME in Czarnitzki’s study do no R&D due 
to financial constraints, compared to 14% of larger firms 
(Czarnitzki, 2006). This result is a strong indicator of the 
need for R&D funding to be accessible to SME, if 
innovation from these firms is seen as part of the plan to 
diversify the economy and suggests that the application 
processes need to be designed with SME applicants in 
mind – for at least some of the available funds.  
Czarnitzki (2006) also found HVMS start-ups 
faced a higher cost of capital compared to larger 
established businesses, and that larger firms preferred 
using internal funds to support R&D. As an HVMS start-up 
is likely to be an innovation-based business facing 
financial constraints on its R&D, and yet is the very type 
of business likely to lead to diversification of an economy, 
it is logical that supporting these firms is important. 
The increasing significance of SME in the EU 
economy is contrasted with their low participation in R&D 
funding mechanisms. Gilmore, Galbraith & Mulvenna 
(2013) call for such mechanisms to be made more SME 
friendly by addressing the barriers to their participation.  
The USA supports SME R&D efforts through 
strategies such as the SME innovation research and 
technology transfer programmes through the Department 
of Defense, and federal acquisition programmes which 
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require SME to have a ‘fair share’ of federal business 
(Foster, 2004). An example is the Small Business Industry 
Research Programme [SBIR] which requires 2.5% of all 
federal procurement to go to SME (Goran Roos, personal 
communication, April 10, 2013). 
The published research does not have a HVMS 
SME focus although these businesses are increasingly 
important in all economies for their contribution to 
employment, and are seen as a rich source of innovation 
(Gilmore, Galbraith & Mulvenna, 2013; Sandu, 2010). Both 
of these factors suggest that SME are going to be a key 
player in any NIS, and yet they are apparently not being 
given a voice through research.  
The consistent lack of research into the views of 
the users of the R&D funding systems around the world is 
surprising, as most of the macro level research is aimed at 
improving the outcomes from the systems. It would be 
fruitful to ask the users of the system where they see the 
problems and opportunities for improvement. 
The co-funding opportunities offered by the NIS 
could be a key enabler of HVMS SME. The aim of this 
research is to uncover and address any issues facing 
HVMS SME in accessing these opportunities. 
 
Method 
The method was comprised of the research question, 
What is the experience of HVMS SME when applying for 
government R&D co-funding? and a series of semi-
structured interviews with businesses identified as fitting 
our HVMS interest group. This approach was seen as the 
first part of a two-stage project which would develop 
propositions for testing across a much larger sample with 
a quantitative survey in phase two, following a grounded 
theory development of those propositions (phase two is in 
development for late 2015). 
Respondents were found by accessing the 
government Who got funded? online database (Ministry of 
Business, Innovation & Employment, 2012).  The database 
declares details about the businesses that received 
funding, as well as purpose, amount and date. Businesses 
that had received funding from 2010 to 2012 were sorted 
to identify those fitting the HVMS SME group following 
the Martin Jenkins report (Martin, Jenkins & Associates, 
2012). Several large businesses were also included as the 
data showed a considerable amount of funding went to 
businesses that are not SME. Furthermore the larger 
business experience of resourcing an application could 
provide an informative contrast to the SME perceptions of 
the difficulty of completing an application (if this was, as 
the anecdotes suggested, an issue). 
A list was completed, and the businesses in two 
regions (Auckland and Wellington) were asked to 
participate in the research. There was caution on the part 
of the businesses who had received funds, as many were 
concerned that any future applications may be at risk if 
their identity was known. 
After assurance that the identities of respondents 
would not be released, we arranged interviews with a 
varied sample of businesses as shown in table one. 
There are two limitations to the sample as it only includes 
successful funding applicants (it was not possible to trace 
unsuccessful applicants), and the funds were awarded 
under the previous agency (MSI), so the results do not 
directly apply to the new situation with Callaghan 
Innovation, except as lessons learnt.  
Industry Number Size range (employee count) 
Pharmaceuticals 2 3 - 300 
Software 3 5 - 80 
Hi tech manufacturing 3 7- 25 
Engineering 3 5 - 40 
Niche manufacturing 2 1 - 10 
Electronics 1 4 
 
Table 1. 
Survey respondents (successful co-
funding applicants) by business type and 
size. 
For analysis, the largest forms in each of these 
catagories was not included in SME counts, 
having employee numbers above 19 people.  
The sample for this research therefore 
comprises 11 SME and three larger businesses. 
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This is an important distinction as the funding 
arrangements were going through substantial changes 
during our interviewing period with the establishment 
of Callaghan Innovation which effectively replaces the 
agencies featured in this research (Raine, Teicher & 
O’Reilly, 2011), and recombines many of the funding 
opportunities for HVMS SME into new products (Joyce, 
2013). 
Interviews were conducted with the person 
responsible for the application at the time, or the CEO 
of the business. Interviews were recorded, transcribed 
and then analysed using thematic analysis. All 
interviewees had received at least one round of funding, 
and we asked each to describe the process of applying for 
funds.  When needed, we prompted interviewees for 
factual information by asking questions such as, How long 
did it take to get the information? and How long did it 
take from initial contact to receiving funds? For the most 
part little prompting was required and the conversation 
flowed to cover many areas of their relationship with the 
agencies they dealt with, and the overall funding 
ecosystem. 
The current sample is biased as all participants 
have received funding, and could be expected to be 
happier with the process than a sample of unsuccessful 
applicants. It is also potentially biased since we 
interviewed only those who agreed to take part, and it’s 
possible that those with strong views, either positive or 
negative, would be more likely to participate. 
As the interviews progressed it became clear that 
the views of several groups were important to the 
discusssion. These groups included independent 
consultants advising applicants, regional funding 
coordinators (staff from regional bodies such as ATEED, 
Grow Wellington, Canterbury Development Corporation), 
and other players in the funding industry such as venture 
capital firms, and investment angels.  
Following a “snowball sampling method” (Bryman 
& Bell, 2011, p. 192) we expanded the range of 
respondents to include the wider industry as shown in 
table two. This created problems for the researchers in 
maintaining focus on the original question in a context 
which was changing almost daily as we worked. 
From this sampling over a period of seven months 
we had 28 interviews which covered many perspectives 
on the innovation funding system in New Zealand, with 
the majority focused on the business applicants’ 
perspectives. These interviews were analysed along with 
documents on funding policy, Callaghan Innovation 
establishment documents, and other completed research. 
The documents were taken from government and non-
government sources. 
A draft report was circulated in June 2014 to 
respondents and other interested parties and received 
generally positive feedback. Minor alterations were made 
to the report in response to the feedback received.  The 
final report (July 2014) was then sent to Callaghan 
Innovation Ltd and MBIE, and discussions are continuing. 
This paper is based on that report (Kearns & Beale, n.d.). 
 
Results 
The results presented below are mainly taken from the 
interviews with applicants (see table one), regional 
funding partners, and independent contractors (see table 
two).  Other interviews were useful in providing context, 
but did not focus directly on the research question, and so 
are excluded from this analysis.   
The presentation of results begins with the co-
funding application process from the perspectives of the 
applicants and funding agencies.These are followed by 
views of the consultants who are contracted to applicants 
to help complete applications. 
 
Co-funding application process:  
Applicant views 
A significant number of the SMEs we interviewed found 
 
Organisation Number of 
respondents 
Regional cofunding agency staff 5 
Independent funding contractors 2 
Venture capital industry spokesperson 1 
Strategic investment partners/advisors 3 
Callaghan Innovation staff 3 
 
Table 2. 
Expanded range of respondents (innovation funding 
ecosystem) by organisation 
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that the process was frustrating, and too time consuming. 
The time taken to complete an application varied from a 
minimum of 1-2 weeks. Elapsed time (while waiting for 
approval) was often several months. The R&D Manager of 
a large pharmaceutical company said, “The time taken to 
collate the information was from 40 hours up to several 
weeks”, while the CFO of a large software company said, 
“Just one month working, maybe 10 hours each week”.  
The CEO of a small engineering company said:  
 
There was probably, in real terms maybe 60 or 80 
hours to put one together.  I think X worked on his 
for about a week, so that was 40 hours, but…on the 
second time around I guess we’d cut, and paste, and 
pull out of previous applications (CEO, small 
engineering).  
 
All applicants accepted that it was reasonable to 
provide information to justify funding, but some smaller 
organisations found the process not one that they wish to 
repeat, stating “It’s a valuable exercise, but… the smaller 
companies and how I’ve seen it go through can be 
intimidating” (CEO of small pharmaceutical company). 
Similarly the CEO of a medium sized hi tech 
manufacturing company commented that “It is quite 
difficult, I wouldn’t say…it’s insurmountable but there is a 
lot of time involved in it It’s not streamlined in any way, 
shape or form”. 
Issues raised by applicants included the wide range 
and (apparently) marginal relevance of some of the 
information required and they questioned the criteria for 
the funding decision. Even the CFO of a large software 
company said, “The questions were very focused 
on…financial benefits which are the hard 
numbers…It’s…not enough focused on intangible benefits, 
or on financial such as new IP production and the 
knowledge gained”. The CEO of a small pharmaceutical 
company also said, “Their investment criteria are all about 
sales, revenue and profitability.  When you’re profitable 
you don’t need money, go and fund it yourself”.  
There were also questions about the level of detail 
required by the application, with many feeling that the 
details being asked for were of little value as they 
involved (for example) extrapolating revenue projections 
for seven years into the future. While this might be a 
useful planning exercise, the applicants felt that they 
were being asked to commit to forecasts over which they 
had little control: 
 
You have to extrapolate exactly in terms of what 
your costs are, how much is going to be done by the 
mechanical design engineers, how much by the 
electronic engineers, how much by the electrical 
engineers…I mean what was more important, the 
innovative idea was there, the concept, having to do 
it, rather than allocate it out to the various 
functions?” (CEO, large engineering). 
 
Most of the smaller SMEs chose to use an external 
consultant to assist them with applications, and likened 
this to their use of external legal and accounting advisers:  
 
And when we were looking at this particular thing 
we didn't have any internal resource really on hand.  
So we went out to a third party…and he…sat and 
talked to us, and we gave him some of our stock 
standard stuff and he pulled it all together over a 
couple of days and put it in (CEO, small 
pharmaceuticals).  
 
And other applicants would have used business 
consultants if they had known about them: 
 
What would be a great benefit is if you had…wanted 
to have a grant where…there was somebody who 
could come in, spend a day with you full-time.  
Assess the business, get all the information they 
need and make that sort of call (CEO, small 
engineering). 
 
Some applicants who have been successful in the past 
will not apply again:   
 
We’ve got some ideas and technology at the moment 
that we think might be a winner here, there’s no way 
we’re going for a grant on it, it’s just too long winded 
and sort of just too hard, you know (CEO, small 
engineering). 
 
Many commented on the fact that though they had 
received funding for product R&D, it was difficult to get 
  
 
 6 
funding from any source for the other activities required 
to commercialize innovation. The director of a medium 
sized hi tech manufactoring company commented in this 
saying, “Industry needs support in the path to 
commercialization, not just in science and R&D but in the 
forms of marketing messages, product iterations, response 
to markets, regulatory needs, etc”. The CEO of a medium 
sized software company also agreed saying:  
 
I don’t think that’s a Callaghan issue.  I wish they 
interacted more and did some better value add 
but…I wouldn’t say I wish they would fund the 
middle chunk.  What I do wish is that someone 
would fund the middle chunk (CEO, medium 
software). 
 
Co-funding application process:  
Regional funding advisor views 
In assessing applications, agency funding managers told 
us that businesses with an existing track record with a 
management team that understands all aspects of the 
business have the best chance of commercialising 
innovations. One regional funding advisor said, “It’s 
usually harder to get funding to go into start-ups unless 
they have a really good team already, like, that has a track 
record”, while another regional funding advisor 
commented: 
 
And the other way around, when the project is good 
on paper but you don't trust the team … there’s no 
business skills, there’s no sales skills or financial 
skills.  And that’s an area which is much beyond the 
scope of just R&D (Regional funding advisor). 
 
The applicant is more likely to succeed if they have the 
resources they need to benefit from R&D funding: 
 
If you don’t have a track record or if you’ve been 
paying yourself great dividends or whatever then 
that’s going to…hamper your funding application 
because either you don’t have the money or you’ve 
been paying yourself…that can, that can throw a 
little bit of a spanner into the works (Regional 
funding advisor). 
 
Agency staff did not accept that the process was too 
demanding, saying that an applicant that struggled to 
apply would be unlikely to successfully commercialise the 
result of the R&D. Thereby if the process was hard for 
some, it was a good qualifying filter:  
 
The ones that often fail, that I’ve seen, are the ones 
who have a great idea and that great idea comes 
through but R&D is a strategic endeavour in a 
company and in a small company they often have 
people who are both operational and strategic…(in a 
small company)…Every time an operational matter 
will bang a strategic matter on the head, right?  
(Regional funding advisor). 
 
The use of consultants to assist firms with applying for 
funding is generally frowned upon by agencies.  One 
regional funding advisor explained: 
 
It’s frowned upon because it’s a business that is 
applying for the R&D funding and it’s the business 
that should take responsibility for putting the 
application together. Because they know what it is 
that they’re talking about and therefore the quality 
of the application is getting better. If you’re having 
to deal with an external contact of any sort then 
you’ve got to, you’ve got to ask them, and also to 
some extent it’s pretty much our job as well 
(Regional funding advisor). 
 
The issue of funding for only product R&D, (and not any 
other forms of innovation) was widely acknowledged.  
One regional funding advisor stated, “R&D doesn’t look at 
brand, customer engagement or revenue models 
or…business networks, or manufacturing processes. But 
it’s really about the product, right, and what’s tightly 
related to product”. Another regional funding advisor 
stated, “Funding gaps do exist (e.g. for the marketing of a 
new innovation) but successful businesses should be able 
to fund these”, while a third funding advisor said: 
 
You can’t get the R&D funding if you haven’t done 
some (market) validation, but then the funding you 
can get from NZTE to go overseas, that’s much later 
in the process.  And so I think in the ‘in between’ 
there is a gap there (Regional funding advisor). 
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`There was no consistent process for measuring the 
impact of the funding.  It seems to have been usually 
confined to an audit of whether money was spent on what 
was intended, rather than assessing the progress of the 
company towards commercialising the innovation for 
which the funding had been awarded. 
Impact assessment was something that most regional 
funding partners had heard about, and was often referred 
to in the context of someone “doing some work on it”.  
But no-one we spoke to had actually seen anything that 
resembled a robust process: 
 
There is a condition as part of, I think it’s funding 
application over $30,000, that Callaghan Innovation 
and its predecessors can follow up, as various time 
periods after an application has been completed, to 
determine the outcomes and where the tracking, but 
from my investigations and our investigations here 
that’s never actually happened (Regional funding 
advisor). 
 
The lack of follow up research may be a changing thing 
however; according to one regional funding advisor, “Until 
recently there’s never been that drive to actually very 
consciously measure the results of the investments that 
have been made…now, we are now required to report 
on…the results of the investments we recommend…”. 
There were widely differing views on who deserves 
funding. Attitudes ranged from questioning the 
effectiveness of funding businesses that were already 
successful to questioning the effectiveness of funding 
small SMEs that lacked business skills. One regional 
funding advisor’s response to these queries is as follows:  
 
You kind of want to back winners, right, so my 
thought is create winners.  And you can’t create 
them out of thin air, there has to be some substance, 
they are already...  And so if they, ... have no team, no 
financial resources, nothing, well we can’t do it for 
them, or if we could we probably should quit and go 
and do it (Regional funding advisor). 
 
There were also concerns about the recently introduced 
(October 2013) sliding scale (30-50%) in project grants for 
the government portion of the R&D project costs. 
The 50/50 rule was nice and clear cut and everybody 
could rely on it.  Now a company gears up for a 
million dollar project, oh I don’t know if I need 
600,000 or 700,000.  For goodness sake, . . . you go 
to your bank and you say I need either 600 or 700 
and they say what, you don’t know, oh well I’m 
dealing with the government, oh well that’s alright 
then [laughter].  No we don’t know what we’re doing 
either with the government.  See it’s the whole 
customer service thing is wrong.  You’ve got to give 
your customers surety (Regional funding advisor). 
 
Funding follow-up and client management 
(applicants & regional funding partners combined) 
We found that the amount and quality of follow-up was 
generally low. Some applicants did speak in glowing 
terms of having had a relationship manager who became 
a coach, trusted adviser, and someone alert to networking 
opportunities. In one case the funding advisor had been 
invited onto the board as an independent director for one 
year. In another instance the CEO of a medium sized 
software company commented that “the reason he was 
good … he provided value way above and beyond the 
grant … was a kind of a semi business coach, wanting to 
get to know the business, what we were doing, was in 
constant communication”.  But serial applicants felt that 
this type of connection was largely in the past.  For 
example one applicant stated, “Callaghan have become ... 
just a funding body”.  Likewise, the CEO of a large 
software company had the following to say: 
 
If I now look at our relationship, how it’s changed 
with MSI and Callaghan Innovation, is that our fourth 
grant was purely about the money.  It was all about 
what needs to be in the report to get the grant, 
where’s the money going, what’s your monthly 
reporting and what you’ve done with it?  And we 
finished it and we haven’t pro-actively heard a word 
from them since that happened, so it was interesting 
that the relationship that we now have with them 
has just become a funding body (CEO, large 
software). 
 
Similar negative feelings can be viewed in the 
experiences of two different CEOs, both from small 
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pharmaceutical companies: 
 
We spent two weeks writing a proposal, we rang X to 
say, ‘yeah we’ve just got one more question’ and he 
said, ‘oh don’t bother, the money’s all gone’. We said 
‘what do you mean it’s all gone?’ and he said, 
‘they’ve finished, they just took the first 25 or 
whatever that turned up and if they seemed like they 
were okay they just gave them money’.  So we spent 
two weeks getting nothing (CEO, small 
pharmaceuticals). 
 
You stick those in and they don’t even tell you.  They 
come back and say ‘you’re unsuccessful’, they don’t 
tell you why, they don’t tell you what the criteria 
were on which they reached their assessment, all 
those things (CEO, small pharmaceuticals). 
 
There was variable follow-up from funding agencies 
on the business impact of the funding.  Mostly it was 
about audit of the expenditure and the progress of the 
R&D. 
 
 
We have to submit, with invoices we have to submit 
progress reports…they’re quite detailed, they don’t 
just give you the claim and then give you the money. 
You submit an invoice, we do it on a monthly basis. 
But every month we do a breakdown of hours that 
have been spent as well as the goals that have been 
achieved against the goals that we set in the initial 
project (CEO, small engineering).    
 
No-one is coming back from Callaghan saying ‘hey 
…, you’ve now had $X bucks of our money, how’s the 
business going’?  You know, to me I don’t mind 
talking about that and then talking about, well hang 
on guys, who else have you funded?  So that was 
interesting (CEO, large software). 
 
Consultants views 
The views of the applicants and agencies concerning the 
application process are vastly different. Applicants are 
finding the process time consuming and difficult, and are 
subsequently using a consultant to help prepare the 
application. However, the agencies maintain that if the 
application is too hard then the business is not ready for 
funding. The agencies also express strong views about the 
use of consultants and consider them unnecessary middle 
men. 
The agency staff and the consultants have the same 
role but on opposite sides of the public/private divide and 
this shows in their opinions. The agency staff claim the 
hurdles which the applicant has to cross are a necessary 
quality filter, and the consultants exert every effort to get 
their clients application across the line as shown in the 
quote below: 
 
So I think I provide significant benefit to the process. 
I would argue that an application written by me is of 
a very high quality because I know the application 
criteria intimately. I know what the format should 
look like. I coach, cajole, coerce the customer to get 
all the information that’s required, and in fact in 
many cases it’s a very intensive process for me, I’m 
educating the customer about a whole pile of things 
along the way that they do have to be aware of for 
ability to succeed both in R&D and 
commercialisation (Consultant). 
 
Agency staff are concerned that the consultants are 
not adding value to the client’s applications, and simply 
churning funding revenue. One regional funding advisor 
states, “The quality of applications that I’ve seen coming 
through from consultants that have just been putting 
applications together are generally of lower quality”. 
There is also concern that consultants merely duplicate 
the service offered by the agency; “ to some extent it’s 
pretty much our job as well.  So it’s our job” (Regional 
funding advisor). The quality of the consultant and their 
work for the client is the key factor here. One notably 
successful consultant claimed: 
 
So we’re talking about small to medium sized 
business here, but there’s large companies that 
use my services as well.  Not only do they use 
them, they use them again and again.  So I have 
this argument with Callaghan regularly if I 
provided no value then no one would ever engage 
me (Consultant). 
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Discussion 
There are four themes that emerge from these interviews 
as being central to the HVMS SME perspective: 1) the 
application criteria, 2) the application process, 3) the 
relationship with regional funding partners, and 4) the 
role of consultants. 
 
The Application Criteria 
Applicants felt the criteria included detailed financial 
forecasts for up to five years which could not be made 
with any real confidence, given the time frame and the 
vagaries of being an SME. It may be that the regional 
funding partner takes a more relaxed interpretation of 
these forecasts as being indicative, or aspirational, but 
applicants thought they were being asked for firm 
commitments. This was a key feature in the criteria being 
seen as unreasonable and narrowly focused.  
There did not appear to be opportunity for 
applicants to discuss improved capability which would 
result from their gaining funding. This, and other similar 
qualitative measures of success were absent, which seems 
inconsistent with the focus on ‘technical stretch’ as a 
primary eligibility factor.  
There was universal concern about the ‘path to 
market’. This is required to be addressed in the R&D 
application, and clearly is important to both the funding 
applicant and the regional funding partner to ensure a 
return on investment. The concern of the HVMS SME is 
that there is no funding support for commercialisation, 
which they all maintain is at least as costly and 
challenging as the technology development that can 
attract funding. The problem of the ‘prototype left on the 
shelf’ through lack of resources to continue down the path 
to market, may be widespread, and if so, represents a 
failed policy setting requiring urgent attention. 
Applicants were asked to demonstrate a path to 
market for something they could not yet do (hence 
technical stretch), which appears to be a focus on short 
term returns, whereas the medium to long term value of 
the funding may be much greater in building capability 
within the firm. 
New Zealand Trade and Enteprise [NZTE] is the 
agency with responsibility for ‘path to market’ assistance, 
but the consistent story from HVMS SME was that NZTE 
was only interested in firms much larger than themselves, 
and on the NZTE ‘top 500 list’. This is an untested 
perception, as we did not get comment from NZTE. 
Whatever the case, there does seem to be a gap between 
completing successful R&D (as an HVMS SME) and being 
able to access support for market development from NZTE 
similar to the ‘chasm’ Moore (2006) talks about in high 
technology markets. Assisting small firms who have 
completed successful R&D to commercialise may unlock 
greater economic benefit than the existing funding 
practices. 
 Applicants were generally unaware of, or 
confused by, the recent changes to the co-funding 
products introduced by Callaghan Innovation in late 2013. 
While this is understandable given the contemporary 
nature of the changes, the HVMS SME we spoke to could 
not see any merit in the sliding scale introduced as part of 
the R&D project grants (which is most relevant to them, 
as project grants are aimed at first time applicants). 
 
The Application Process 
There was a clear division in opinion on the application 
process with the larger firms finding it manageable, 
(sometimes putting a three person project team onto an 
application), and the HVMS SME who did not have the 
staff capacity, or possibly the skill set to do this. The 
HVMS SME are thus in a double bind through not having 
the capacity to complete the application, and also being 
discouraged from employing a consultant to do it.  
There was general concern about the time taken 
for the funding approval. The typical timeframe was about 
four months with time lines of up to one year being 
mentioned. Speed to market is a critical success factor for 
many of the high technology products that result from 
R&D (which is often happening in parallel elsewhere), and 
some degree of urgency is called for from the regional 
funding partner. 
 
Relationship with Regional Funding Partner 
This was highly variable from the perspective of the 
applicant and it is clear that the incumbent staff vary in 
inclination, motivation, and approach to their role, all of 
which affect outcomes. There were some very well 
regarded individuals, but this was countered by a 
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perceived lack of continuity as staff changed at the 
regional funding partner. 
Several interviewees expressed surprise that after 
the rigorous application process, there had been no 
further contact from the regional funding partner as to 
outcomes of the project. The general view was that 
accurate contract administration was the only issue of 
interest to the regional funding partner once the money 
was ‘out the door’. 
This was also a concern, for the majority of the 
regional funding advisors, who felt that the data was 
readily available to assess co-funding effectiveness, but 
that no work was being done on this. They concurred with 
the view that the aim appears to be get the ‘money out 
the door – job done’, and that little, if any monitoring of 
the research spending was being done, even though the 
provision for this is in every application. 
This appears to reflect a bureaucratic and risk 
minimising approach from the regional funding partner, in 
which process is dominating over purpose. The 
opportunity for informed decisions based on reviewing 
funding data is being lost, and with it, possible 
improvements for fine tuning the application processes.  
The comment that the regional funding partners 
appeared to have no concept of customer relationships 
was put forth forcefully by an articulate minority. The lack 
of post funding review, could support this opinion as there 
is no-one from the regional funding partner asking the 
question ‘how are we doing?’ 
Several businesses expressed the idea that they 
felt they had ‘had a funding advisor’ in the past, but that 
this relationship had been lost with the introduction of 
Callaghan Innovation. Again this may be a transitional 
issue which will solve itself in the near future. Subsequent 
discussion with Callaghan Innovation funding managers 
did point to a period of strategy development though 
2014 – early 2015. This is to be followed by establishing 
networks of businesses using funding as a tool for 
encouraging collaboration, and this suggested a move 
towards proactive relationship building. 
During the interviews with regional co-funding 
advisors we were surprised to find that there is no 
national forum or meeting of these staff, who are 
essentially members of the same team, delivering 
Callaghan Innovation co-funding through regional 
agencies. In fact many of them did not even recognise the 
names of their counterparts in other regions. As there are 
less than 20 staff nationwide in this team it seemed that 
strong consistency in policy interpretation, and close 
communication with regional funding agencies is entirely 
possible. In a country where collaboration to overcome 
small scale has been a catch-cry for at least a decade, the 
leading agency of the NIS could model this behaviour 
successfully. This would overcome much of the perceived 
inconsistency issues between regions, and between the 
regional partner and the central funding agency. 
 
The Role of Consultants 
This was the most contentious issue with the applicant 
businesses seeing consultants as very useful, the regional 
funding partners seeing them as unnecessary middlemen, 
and the consultants seeing themselves as the funding 
experts. 
There is definitely a call for some form of 
assistance to HVMS SME completing applications, as they 
clearly find it difficult, and even (some) successful 
applicants are not keen to repeat the experience. The 
institutional response was commonly ‘if they can’t do it, 
they are not ready for funding’, but this does not consider 
resourcing issues, or the fact that complex application 
forms are not the usual order of business for HVMS SME 
CEOs.  
The competing demands on staff time and effort, 
plus the nature of the task argue strongly for seeking 
expert advice on this, which is the natural role of 
consultants. Some of the regional funding partners 
claimed that they should be seen as filling this role, but it 
was clear that the applicants perceived these staff as 
belonging to the government rather than being on their 
(applicant) side of the table. As such, the degree of 
interaction and trust was somewhat circumspect. 
The regional funding advisors expressed the view 
that contractors are making good applications from poor 
applicants, and this was a central argument against 
contractor involvement. It is probable that the private 
contractors are incentivised to work with only those who 
they perceive as likely to succeed in order to protect their 
reputation, and this counters the regional funding partner 
view to some degree. If consultants are in the business of 
picking winners to work with, then it makes no sense for 
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them to pick weak candidates. The consultants made valid 
points about their ability to qualify an applicant early, 
being more finely tuned than the regional funding 
advisors, as their ongoing livelihood depended on having 
a track record of success. 
Even if contractors were leading (as opposed to 
supporting) the applicant, the business in question would 
be receiving valuable professional development by being 
coached through the application, and the overall objective 
of business development is still served, although less 
directly. 
A further point made by contractors was that they 
engage in a ‘deep dive’ to fully understand the business 
when helping with the application. This time commitment 
is only possible on a consultant-client basis, and the 
regional funding partners could not have the same level 
of involvement. 
It is probable that the views of consultants and 
regional funding partners have merit, in that there are 
poorly performing consultants who compound problems 
in the system, and that there are high performing 
consultants who provide useful input to the R&D co-
funding process. Such  consultants possibly outperform 
regional funding partners in service delivery. 
 
Conclusion 
This research was an exploration of the perspectives of 
R&D co-funding applicants on the application process, 
undertaken during a time of rapid change in the 
institutional arrangements for this. The need for it was 
clear as the existing literature has very little empirical 
research into how the co-funding processes are actually 
working, at the level of the applicant and application 
process. 
It is clear that the application process serves two 
purposes. One is to provide the regional funding partner 
with enough information to make a decision and the other 
is to force the applicant through some disciplined thinking 
to further develop their proposal. All parties agreed with 
the need for thorough processes when risking taxpayers’ 
money, but the way to achieve this was not agreed upon, 
with the use of contractors to help with the application 
being the main stumbling block.   
The application criteria do not reflect the reality 
of HVMS SME using the funding to develop business 
capability as well as a prototype. The focus of the R&D 
co-funding on product based innovation is a significant 
constraint on innovation, especially given the claim that 
many prototypes do not make it to market through lack of 
resources once the R&D funding is used. 
The outcomes of the R&D co-funding process are 
not being tracked closely enough to allow informed fine 
tuning. This appears to be a significant problem and one 
that could easily be solved as the data is available in the 
agency records of past applications, and in the outcomes 
for each business, recorded in their annual accounts. 
Although there always has been a process for this to 
happen, it has not occurred. 
The NIS is still developing. The parts are being 
positioned, but are not yet working in a connected fashion 
from the perspective of the HVMS SME. There has been 
considerable effort in designing the NIS and 
implementing the structures, such as Callaghan 
Innovation and New Zealand Venture Investment Fund. 
Now it is time to look at efficiencies of agency interaction 
and the support of businesses. 
Priorities from this point are: 
 
1. Begin analysing outcomes of R&D co-funding from 
the existing database of previous years. 
2. Take the findings from this into consideration when 
considering policy settings for Callaghan Innovation 
co-funding processes with their regional funding 
partners. 
3. Ensure consistent interpretation of policy by 
regional funding partners nationwide. 
4. Reconsider the usefulness of contractors in co-
funding applications. 
 
Future Research 
A weakness of this work is the lack of coverage of 
unsuccessful applicants. Their story may be critical to 
establishing whether these businesses are HVMS SMEs 
which are failed by the NIS, or whether NIS is getting it 
right by not co-funding their activity. 
It would also be useful to update the research after 
the new funding regime under Callaghan Innovation is 
fully operational sometime after 2015.
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